UPLOAD Filing
Kyverna Therapeutics, Inc.
Date: March 30, 2026 · CIK: 0001994702 · Accession: 0000000000-26-003199
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294645
Letter
Re: Kyverna Therapeutics, Inc. Registration Statement on Form S-3 Filed March 26, 2026 File No. 333-294645 Dear Warner Biddle:
March 30, 2026
Warner Biddle Chief Executive Officer Kyverna Therapeutics, Inc. 5980 Horton St., STE 550 Emeryville, CA 94608
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Samantha Eldredge, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 30, 2026 Warner Biddle Chief Executive Officer Kyverna Therapeutics, Inc. 5980 Horton St., STE 550 Emeryville, CA 94608 Re: Kyverna Therapeutics, Inc. Registration Statement on Form S-3 Filed March 26, 2026 File No. 333-294645 Dear Warner Biddle: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Samantha Eldredge, Esq. </TEXT> </DOCUMENT>